Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

Cited In for PubMed (Select 19877054)

1.

Quantitative assessment of oral mucosa and labial minor salivary glands in patients with Sjögren's syndrome using swept source OCT.

Grulkowski I, Nowak JK, Karnowski K, Zebryk P, Puszczewicz M, Walkowiak J, Wojtkowski M.

Biomed Opt Express. 2013 Dec 16;5(1):259-74. doi: 10.1364/BOE.5.000259. eCollection 2013 Dec 16.

2.

Immunomodulatory drugs: oral and systemic adverse effects.

Bascones-Martinez A, Mattila R, Gomez-Font R, Meurman JH.

Med Oral Patol Oral Cir Bucal. 2014 Jan 1;19(1):e24-31. Review.

3.

B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies.

Leandro MJ.

Arthritis Res Ther. 2013;15 Suppl 1:S3. doi: 10.1186/ar3908. Epub 2013 Mar 25. Review.

4.
5.

Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model.

Horvath S, Nazmul-Hossain AN, Pollard RP, Kroese FG, Vissink A, Kallenberg CG, Spijkervet FK, Bootsma H, Michie SA, Gorr SU, Peck AB, Cai C, Zhou H, Wong DT.

Arthritis Res Ther. 2012 Nov 1;14(6):R238. doi: 10.1186/ar4081.

6.

Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome.

Roescher N, Lodde BM, Vosters JL, Tak PP, Catalan MA, Illei GG, Chiorini JA.

Oral Dis. 2012 Jan;18(1):96-106. doi: 10.1111/j.1601-0825.2011.01852.x. Epub 2011 Sep 14.

7.

Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: macrophage harbingers of disease severity.

Greenwell-Wild T, Moutsopoulos NM, Gliozzi M, Kapsogeorgou E, Rangel Z, Munson PJ, Moutsopoulos HM, Wahl SM.

Arthritis Rheum. 2011 Oct;63(10):3103-15. doi: 10.1002/art.30465.

8.

Genetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies.

Segal BM, Nazmul-Hossain AN, Patel K, Hughes P, Moser KL, Rhodus NL.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Jun;111(6):673-80. doi: 10.1016/j.tripleo.2011.01.040. Epub 2011 Apr 16.

9.

What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?

Kallenberg CG, Vissink A, Kroese FG, Abdulahad WH, Bootsma H.

Arthritis Res Ther. 2011 Feb 28;13(1):205. doi: 10.1186/ar3234. Review.

10.

Preclinical validation of salivary biomarkers for primary Sjögren's syndrome.

Hu S, Gao K, Pollard R, Arellano-Garcia M, Zhou H, Zhang L, Elashoff D, Kallenberg CG, Vissink A, Wong DT.

Arthritis Care Res (Hoboken). 2010 Nov;62(11):1633-8. doi: 10.1002/acr.20289. Epub 2010 Jul 8.

11.

Autoimmunity at the ocular surface: pathogenesis and regulation.

Stern ME, Schaumburg CS, Dana R, Calonge M, Niederkorn JY, Pflugfelder SC.

Mucosal Immunol. 2010 Sep;3(5):425-42. doi: 10.1038/mi.2010.26. Epub 2010 May 19. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk